Tranexamic acid for childbirth: why, when, and for whom
Loı̈c Sentilhes(Université de Bordeaux), Catherine Deneux‐Tharaux(Boston University), Hugo Madar(Hôpital Cochin), Benjamin Merlot(Hôpital de la Croix-Rousse), Alizée Froeliger(Université de Bordeaux), Aurélien Mattuizzi(Twitter (United States)), B. Elleboode(Université de Bordeaux)
Cited by 18
Related Papers
Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection
|JAMA Pediatrics|2021|1.4k
Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study
|American Journal of Obstetrics and Gynecology|2021|310
Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery
|New England Journal of Medicine|2021|272
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth
|American Journal of Obstetrics and Gynecology|2020|197
Underreporting of Pregnancy-Related Mortality in the United States and Europe
|Obstetrics and Gynecology|2005|188